Best Practices in Safety Signal Analytics — Managing Today and Preparing for Tomorrow
With up to 30-50% annual growth in adverse event cases, how ...
Blog: Automation in ICSR Processing – Is Artificial Intelligence the Paradigm Shift in Pharmacovigilance?
Artificial intelligence (AI), machine learning, deep learning, natural language processing ...
Breaking Down Silos across the Life Sciences Enterprise Helps Drive Innovation
Silos have long plagued the life sciences industry, and nowhere ...
Benefits of a True SaaS Safety System
The Shift to the Cloud Historically, firms relied heavily on ...
Benefits of Integrating Your Medical Information and Safety Workflows
Data is the lifeblood of businesses today. Data informs strategy ...
Best Practices for Digitally Transforming Pharmacovigilance Processes
On June 9th, 2020 ArisGlobal held a webinar titled “Pharmacovigilance and ...
Balancing Speed, Safety, and Risks in a Global Pandemic
In the age of Covid-19, the cause of a global ...
Automation in Pharmacovigilance: A Real-World Implementation Story
In the last of our three-part blog series, we share the poll results to the question "What concerns do you have when it comes to automating PV process?" and analyze the responses. Read the blog to see how your responses might compare.
Beat the Clock with Future-Ready ICH E2B R3 Compliant Safety Database Systems for Chinese Submissions
In order to stay compliant with NMPA requirements (submitting all post-marketing ADRs in ICH E2B (R3) format), drug manufacturers are required to procure an electronic safety database that is.....
Benefits & Challenges of Artificial Intelligence in Pharmacovigilance
Pharmacovigilance is at a crossroads. The best, most innovative way forward for PV departments may well be automation, as they address the challenges (or market pull factors) and opportunities (or technology push capabilities).
